《血癌发现》(Blood Cancer Discovery)是一本以Multiple综合研究为特色的国际期刊。该刊由NLM (Medline)出版商该刊已被国际重要权威数据库SCIE收录。期刊聚焦Multiple领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术交流的信息窗口与平台。该刊2023年影响因子为11.5。CiteScore...
JCR分区(2023-2024年最新版) Blood Cancer Discovery杂志 JCR分区信息 按JIF指标学科分区 学科:HEMATOLOGY 收录子集:ESCI 分区:Q1 排名:7 / 97 百分位: 93.3% 学科:ONCOLOGY 收录子集:ESCI 分区:Q1 排名:24 / 322 百分位: 92.7% 按JCI指标学科分区 ...
This journal has been indexed by ESCI and is planned to be indexed by SCIE, with an expected high impact factor. 《血癌发现》是由美国癌症研究学会(AACR)出版的国际同行评审期刊,专注于血液系统疾病的基础、转化和临床研究。该期刊旨在发表在血液病领域具有重大发现及较大影响力的研究内容,推动血液病研究...
2.4.3 Pancreatic cancer Interplay between tumour cells and mesenchymal cells in pancreatic ductal adenocarcinoma (PDAC) stroma, or CAFs has been suggested to be an important factor in influencing carcinogenesis. This interaction is facilitated by secreted components such as amphiregulin and matrix metallop...
Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. Topics of particular inter...
Azeem MI, Nooka AK, Shanmugasundaram U, Cheedarla N, Potdar S, Manalo RJ, et al. Impaired SARS-CoV-2 variant neutralization and CD8+ T cell responses following 3 doses of mRNA vaccines in myeloma: correlation with breakthrough infections. Blood Cancer Discov. 2023;4:106–17. ...
Blood Cancer J. 2023;13:8. Article PubMed PubMed Central Google Scholar Chuleerarux N, Manothummetha K, Moonla C, Sanguankeo A, Kates OS, Hirankarn N, et al. Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis. Blood Adv. ...
The GWAS summary statistics of blood traits and cancer risk studies were obtained from the corresponding data sources, detailed in Additional file 1: Table S1. The study did not require individual data. For each of the variant-summary statistics, the following quality controls were applied, removi...
Additionally, functional experiments are needed to validate the specific mechanisms of action of ADAM23 in the development of head and neck cancer. The identification of ADAM23 as a causal risk factor for head and neck cancer has important implications for risk stratification, early detection, and ...
Nat. Immunol., 24 (2023), pp. 1-15 CrossrefGoogle Scholar 7 J.M. Klco, C.G. Mullighan Advances in germline predisposition to acute leukaemias and myeloid neoplasms Nat. Rev. Cancer, 21 (2021), pp. 122-137 CrossrefView in ScopusGoogle Scholar 8 E.L. Bao, S.K. Nandakumar, X. ...